Published in Immunotherapy on July 01, 2010
Recipient-derived EDA fibronectin promotes cardiac allograft fibrosis. J Pathol (2012) 1.57
Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension. Cardiovasc Res (2012) 1.19
Key Features of the Intragraft Microenvironment that Determine Long-Term Survival Following Transplantation. Front Immunol (2012) 0.97
IL-6 promotes cardiac graft rejection mediated by CD4+ cells. J Immunol (2011) 0.89
Tim-1-Fc suppresses chronic cardiac allograft rejection and vasculopathy by reducing IL-17 production. Int J Clin Exp Pathol (2014) 0.81
Role of LPA and the Hippo pathway on apoptosis in salivary gland epithelial cells. Exp Mol Med (2014) 0.80
Matricellular proteins and matrix metalloproteinases mark the inflammatory and fibrotic response in human cardiac allograft rejection. Eur Heart J (2012) 0.79
IL-13 signaling via IL-13Rα2 triggers TGF-β1-dependent allograft fibrosis. Transplant Res (2013) 0.78
Novel Application of Localized Nanodelivery of Anti-Interleukin-6 Protects Organ Transplant From Ischemia-Reperfusion Injuries. Am J Transplant (2017) 0.76
Targeted complement inhibition and microvasculature in transplants: a therapeutic perspective. Clin Exp Immunol (2015) 0.75
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature (2006) 46.36
Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science (2003) 14.04
TGFbeta signaling in growth control, cancer, and heritable disorders. Cell (2000) 12.38
Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2009) 12.34
Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity (2008) 10.26
Transforming growth factor beta in tissue fibrosis. N Engl J Med (1994) 9.73
Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol (2006) 9.53
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med (2007) 9.51
Interleukin-6: an overview. Annu Rev Immunol (1990) 7.48
Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol (2009) 7.34
Regulatory T cells in transplantation tolerance. Nat Rev Immunol (2003) 6.42
IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med (2009) 5.05
Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature (1990) 4.90
Structural and functional characterisation of cardiac fibroblasts. Cardiovasc Res (2005) 4.79
NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ Res (2005) 4.66
Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation (2003) 4.09
Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature (1992) 3.96
Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J Immunol (1998) 3.70
The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer. Trends Mol Med (2008) 3.68
Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res (2009) 3.66
The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol (1998) 3.65
The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu Rev Pharmacol Toxicol (2005) 3.47
Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol (1996) 3.47
IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest (2007) 3.31
Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity (2001) 3.27
Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol (2005) 3.17
Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: from innocent bystander to active participant. Circ Res (2001) 2.66
Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation. Circulation (2007) 2.43
A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy. J Exp Med (2008) 2.26
CTGF expression is induced by TGF- beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J Mol Cell Cardiol (2000) 2.25
Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol (1994) 2.12
Essential involvement of IL-6 in the skin wound-healing process as evidenced by delayed wound healing in IL-6-deficient mice. J Leukoc Biol (2003) 2.09
Inhibition of myofibroblast apoptosis by transforming growth factor beta(1). Am J Respir Cell Mol Biol (1999) 2.09
Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc Res (1993) 2.04
Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium. Circ Res (1988) 2.02
Chronic rejection. Immunity (2001) 1.98
Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med (1996) 1.93
An essential role for fibronectin extra type III domain A in pulmonary fibrosis. Am J Respir Crit Care Med (2007) 1.91
IL-6 rescues resting mouse T cells from apoptosis. J Immunol (1997) 1.89
The myofibroblast: phenotypic characterization as a prerequisite to understanding its functions in translational medicine. J Cell Mol Med (2007) 1.88
IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta , NF-kappaB, and AP-1 activation. Am J Physiol Heart Circ Physiol (2007) 1.82
IL-6 produced by dendritic cells from lupus-prone mice inhibits CD4+CD25+ T cell regulatory functions. J Immunol (2007) 1.82
The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology. Biochem Cell Biol (2003) 1.80
Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol (1998) 1.75
Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection. J Immunol (2009) 1.74
IL-6 regulates neutrophil trafficking during acute inflammation via STAT3. J Immunol (2008) 1.69
IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation. Proc Natl Acad Sci U S A (2005) 1.66
Cardiac transplantation in man. VII. Cardiac allograft pathology. Circulation (1970) 1.65
Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung. Am J Physiol Lung Cell Mol Physiol (2001) 1.60
Protein S100A4: too long overlooked by pathologists? Am J Pathol (2002) 1.59
Connective tissue growth factor promotes fibrosis downstream of TGFbeta and IL-6 in chronic cardiac allograft rejection. Am J Transplant (2009) 1.59
Cardiac allograft remodeling after heart transplantation is associated with increased graft vasculopathy and mortality. Am J Transplant (2008) 1.56
Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation (1995) 1.53
Biology of fibroblasts and myofibroblasts. Proc Am Thorac Soc (2008) 1.51
Fibrogenic cytokines and connective tissue production. FASEB J (1994) 1.51
Reprogramming of vascular smooth muscle alpha-actin gene expression as an early indicator of dysfunctional remodeling following heart transplant. Cardiovasc Res (2002) 1.49
Tregs and transplantation tolerance. J Clin Invest (2004) 1.49
Transforming growth factor beta-induced endothelial-to-mesenchymal transition: a switch to cardiac fibrosis? Trends Cardiovasc Med (2008) 1.47
Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes. J Biol Chem (2000) 1.46
Interleukin-6 regulation of transforming growth factor (TGF)-beta receptor compartmentalization and turnover enhances TGF-beta1 signaling. J Biol Chem (2005) 1.45
Th17-polarized immune response in a murine model of hypersensitivity pneumonitis and lung fibrosis. J Immunol (2009) 1.41
Cardiac allograft vasculopathy: a review. Circulation (1997) 1.38
Interleukin-6 inhibits transforming growth factor-beta-induced apoptosis through the phosphatidylinositol 3-kinase/Akt and signal transducers and activators of transcription 3 pathways. J Biol Chem (1999) 1.37
Neutrophil adherence to isolated adult cardiac myocytes. Induction by cardiac lymph collected during ischemia and reperfusion. J Clin Invest (1992) 1.36
Hypertrophic stimuli induce transforming growth factor-beta 1 expression in rat ventricular myocytes. J Clin Invest (1994) 1.36
Connective tissue growth factor: structure-function relationships of a mosaic, multifunctional protein. Growth Factors (2008) 1.36
Cardiac allograft vasculopathy after heart transplantation: risk factors and management. J Heart Lung Transplant (2004) 1.33
Connective tissue growth factor is crucial to inducing a profibrotic environment in "fibrosis-resistant" BALB/c mouse lungs. Am J Respir Cell Mol Biol (2004) 1.31
Migration of mesenchymal stem cells to heart allografts during chronic rejection. Transplantation (2003) 1.26
TLR signals promote IL-6/IL-17-dependent transplant rejection. J Immunol (2009) 1.26
Resveratrol inhibits high glucose-induced PI3K/Akt/ERK-dependent interleukin-17 expression in primary mouse cardiac fibroblasts. Am J Physiol Heart Circ Physiol (2008) 1.25
Cardiac fibrosis and inflammation: interaction with hemodynamic and hormonal factors. Cardiovasc Res (1999) 1.21
Arterial gene transfer of the TGF-beta signalling protein Smad3 induces adaptive remodelling following angioplasty: a role for CTGF. Cardiovasc Res (2009) 1.20
Interactions between cardiac cells enhance cardiomyocyte hypertrophy and increase fibroblast proliferation. J Cell Physiol (2005) 1.19
Structural and functional coupling of cardiac myocytes and fibroblasts. Adv Cardiol (2006) 1.18
Human recombinant IL-6/B cell stimulatory factor 2 augments murine antigen-specific antibody responses in vitro and in vivo. J Immunol (1988) 1.18
Influence of cytokines and growth factors in ANG II-mediated collagen upregulation by fibroblasts in rats: role of myocytes. Am J Physiol Heart Circ Physiol (2004) 1.16
Connective tissue growth factor and cardiac fibrosis. Acta Physiol (Oxf) (2008) 1.15
Myofibroblast transdifferentiation in obliterative bronchiolitis: tgf-beta signaling through smad3-dependent and -independent pathways. Am J Transplant (2006) 1.14
Rapid upregulation of CTGF in cardiac myocytes by hypertrophic stimuli: implication for cardiac fibrosis and hypertrophy. J Mol Cell Cardiol (2004) 1.14
Connective tissue growth factor is a biomarker and mediator of kidney allograft fibrosis. Am J Transplant (2006) 1.14
Elevated tumor necrosis factor-alpha and interleukin-6 in myocardium and serum of malfunctioning donor hearts. Circulation (2000) 1.13
Critical role for IL-6 in hypertrophy and fibrosis in chronic cardiac allograft rejection. Am J Transplant (2009) 1.13
Interleukin-6 is a direct mediator of T cell migration. Eur J Immunol (2004) 1.13
Connective tissue growth factor induces cardiac hypertrophy through Akt signaling. Biochem Biophys Res Commun (2008) 1.12
Role of T cell TGFbeta signaling and IL-17 in allograft acceptance and fibrosis associated with chronic rejection. J Immunol (2009) 1.12
Cardiac fibroblasts: function, regulation of gene expression, and phenotypic modulation. Basic Res Cardiol (1992) 1.10
Contemporary concepts in prevention and treatment of cardiac allograft vasculopathy. Am J Transplant (2006) 1.08
Role of interleukin-6 in cardiomyocyte/cardiac fibroblast interactions during myocyte hypertrophy and fibroblast proliferation. J Cell Physiol (2005) 1.08
IL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in isoproterenol-induced heart failure. Exp Mol Pathol (2009) 1.08
The type II transforming growth factor-beta receptor as a tumor-suppressor gene. Curr Opin Oncol (1996) 1.07
Myocardial collagen remodeling in pressure overload hypertrophy. A case for interstitial heart disease. Am J Hypertens (1989) 1.06
Incidence and progression of transplant coronary artery disease over 1 year: results of a multicenter trial with use of intravascular ultrasound. Multicenter Intravascular Ultrasound Transplant Study Group. J Heart Lung Transplant (1996) 1.06
The origin of renal fibroblasts and progression of kidney disease. Am J Pathol (2009) 1.05
Recombinant human decorin inhibits TGF-beta1-induced contraction of collagen lattice by hypertrophic scar fibroblasts. Burns (2009) 1.03
Circulating interleukin-6 family cytokines and their receptors in patients with congestive heart failure. Heart Vessels (2004) 1.03
The CC chemokine ligand 2 (CCL2) mediates fibroblast survival through IL-6. Am J Respir Cell Mol Biol (2007) 1.03
Direct effects of leptin on size and extracellular matrix components of human pediatric ventricular myocytes. Cardiovasc Res (2005) 0.99
Expression of cytokine genes in human cardiac allografts: correlation of IL-6 and transforming growth factor-beta (TGF-beta) with histological rejection. Clin Exp Immunol (1993) 0.98
Recipient-derived EDA fibronectin promotes cardiac allograft fibrosis. J Pathol (2012) 1.57
CD8+ Th17 mediate costimulation blockade-resistant allograft rejection in T-bet-deficient mice. J Immunol (2008) 1.36
IL-12 p40 homodimer-dependent macrophage chemotaxis and respiratory viral inflammation are mediated through IL-12 receptor beta 1. J Immunol (2003) 1.31
Interferon-gamma expression by intraepithelial lymphocytes results in a loss of epithelial barrier function in a mouse model of total parenteral nutrition. Ann Surg (2002) 1.21
Role of T cell TGFbeta signaling and IL-17 in allograft acceptance and fibrosis associated with chronic rejection. J Immunol (2009) 1.12
New insights on OX40 in the control of T cell immunity and immune tolerance in vivo. J Immunol (2011) 1.06
OX40 costimulation prevents allograft acceptance induced by CD40-CD40L blockade. J Immunol (2009) 1.01
Contrasting alloreactive CD4+ and CD8+ T cells: there's more to it than MHC restriction. Am J Transplant (2003) 1.00
The immunobiology of inductive anti-CD40L therapy in transplantation: allograft acceptance is not dependent upon the deletion of graft-reactive T cells. Am J Transplant (2002) 0.94
Th17 cells and transplant acceptance. Transplantation (2010) 0.90
IL-6 promotes cardiac graft rejection mediated by CD4+ cells. J Immunol (2011) 0.89
Transforming growth factor-beta1 gene transfer is associated with the development of regulatory cells. Am J Transplant (2005) 0.88
Requirement for donor and recipient CD40 expression in cardiac allograft rejection: induction of Th1 responses and influence of donor-derived dendritic cells. J Immunol (2004) 0.88
Peripheral nerve transplantation: the role of chemical acellularization in eliminating allograft antigenicity. J Reconstr Microsurg (2005) 0.88
Graft rejection mediated by CD4+ T cells via indirect recognition of alloantigen is associated with a dominant Th2 response. Eur J Immunol (2005) 0.85
Induced expression of murine gamma2a by CD40 ligation independently of IFN-gamma. J Immunol (2006) 0.83
TGFbeta neutralization within cardiac allografts by decorin gene transfer attenuates chronic rejection. J Immunol (2009) 0.82
IFN-gamma production is specifically regulated by IL-10 in mice made tolerant with anti-CD40 ligand antibody and intact active bone. J Immunol (2003) 0.82
Regulation of alloimmune Th1 responses by the cyclin-dependent kinase inhibitor p21 following transplantation. Surgery (2007) 0.78
Fibroblastic niches prime T cell alloimmunity through Delta-like Notch ligands. J Clin Invest (2017) 0.78
Short-term anti-CD40 ligand costimulatory blockade induces tolerance to peripheral nerve allografts, resulting in improved skeletal muscle function. Plast Reconstr Surg (2006) 0.78
Glucocorticoid-induced TNFR-related protein stimulation reverses cardiac allograft acceptance induced by CD40-CD40L blockade. Clin Dev Immunol (2013) 0.77
Anti-CD40L monoclonal antibody treatment induces long-term, tissue-specific, immunologic hyporesponsiveness to peripheral nerve allografts. J Reconstr Microsurg (2008) 0.77
Engendering allograft ignorance in a mouse model of allogeneic skin transplantation to the distal hind limb. Ann Surg (2015) 0.77
Theoretical and technical considerations for gene transfer into vascularized cardiac transplants. Methods Mol Biol (2003) 0.75